Molecular genetics of Kawasaki disease

Pediatric Research

Volumn 65, Issue SUPPL. 5, 2009, Pages

  Onouchi, Yoshihiro ^a  

^a RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CYCLOSPORIN A; GLUCURONOSYLTRANSFERASE 1A1; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA B44 ANTIGEN; HLA C ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN; INFLIXIMAB; INOSITOL TRISPHOSPHATE 3 KINASE; INOSITOL TRISPHOSPHATE 3 KINASE C; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

DRUG MECHANISM; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HAPLOTYPE; HLA SYSTEM; HUMAN; MOLECULAR GENETICS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINKAGE DISEQUILIBRIUM; MUCOCUTANEOUS LYMPH NODE SYNDROME; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION;

EID: 68049125873     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e31819dba60     Document Type: Review

References (78)

1. Kawasaki T 1967 Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16:178-222
2. Burns JC 2002 Commentary: translation of Dr. Tomisaku Kawasaki's original report of fifty patients in 1967. Pediatr Infect Dis J 21:993-995
3. Kato H, Koike S, Yamamoto M, Ito Y, Yano E 1975 Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr 86:892-898
4. Nakamura Y, Yashiro M, Uehara R, Oki I, Watanabe M, Yanagawa H 2008 Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006. J Epidemiol 18:167-172
5. Holman RC, Curns AT, Belay ED, Steiner CA, Effler PV, Yorita KL, Miyamura J, Forbes S, Schonberger LB, Melish M 2005 Kawasaki syndrome in Hawaii. Pediatr Infect Dis J 24:429-433
6. Fujita Y, Nakamura Y, Sakata K, Hara N, Kobayashi M, Nagai M, Yanagawa H, Kawasaki T 1989 Kawasaki disease in families. Pediatrics 84:666-669
7. Uehara R, Yashiro M, Nakamura Y, Yanagawa H 2003 Kawasaki disease in parents and children. Acta Paediatr 92:694-697
8. Matsuda I, Hattori S, Nagata N, Fruse A, Nambu H 1977 HLA antigens in mucocutaneous lymph node syndrome. Am J Dis Child 131:1417-1418
9. Kato S, Kimura M, Tsuji K, Kusakawa S, Asai T, Juji T, Kawasaki T 1978 HLA antigens in Kawasaki disease. Pediatrics 61:252-255
10. Krensky AM, Berenberg W, Shanley K, Yunis EJ 1981 HLA antigens in mucocutaneous lymph node syndrome in New England. Pediatrics 67:741-743 (Pubitemid 11061309)
11. Krensky AM, Grady S, Shanley KM, Berenberg W, Yunis EJ 1983 Epidemic and endemic HLA-B and DR associations in mucocutaneous lymph node syndrome. Hum Immunol 6:75-77
12. Keren G, Danon YL, Orgad S, Kalt R, Gazit E 1982 HLA Bw51 is increased in mucocutaneous lymph node syndrome in Israeli patients. Tissue Antigens 20:144-146 (Pubitemid 12046007)
13. Chang CC, Hawkins BR, Kao HK, Chow CB, Lau YL 1992 Human leucocyte antigens in southern Chinese with Kawasaki disease. Eur J Pediatr 151:866
14. Oh JH, Han JW, Lee SJ, Lee KY, Suh BK, Koh DK, Lee JS, Oh CK, Kim TG, Choi HB 2008 Polymorphisms of human leukocyte antigen genes in Korean children with Kawasaki disease. Pediatr Cardiol 29:402-408
15. Kaslow RA, Bailowitz A, Lin FY, Koslowe P, Simonis T, Israel E 1985 Association of epidemic Kawasaki syndrome with the HLA-A2, B44, Cw5 antigen combination. Arthritis Rheum 28:938-940 (Pubitemid 15021489)
16. Harada F, Sada M, Kamiya T, Yanase Y, Kawasaki T, Sasazuki T 1986 Genetic analysis of Kawasaki syndrome. Am J Hum Genet 39:537-539
17. Barron KS, Silverman ED, Gonzales JC, St Clair M, Anderson K, Reveille JD 1992 Major histocompatibility complex class II alleles in Kawasaki syndrome-lack of consistent correlation with disease or cardiac involvement. J Rheumatol 19:1790-1793
18. Huang FY, Chang TY, Chen MR, Hsu CH, Lee HC, Lin SP, Kao HA, Chiu NC, Chi H, Liu TY, Liu HF, Dang CW, Chu CC, Lin M, Sung TC, Lee YJ 2007 Genetic variations of HLA-DRB1 and susceptibility to Kawasaki disease in Taiwanese children. Hum Immunol 68:69-74 (Pubitemid 46026887)
19. Fildes N, Burns JC, Newburger JW, Klitz W, Begovich AB 1992 The HLA class II region and susceptibility to Kawasaki disease. Tissue Antigens 39:99-101
20. Onouchi Y, Tamari M, Takahashi A, Tsunoda T, Yashiro M, Nakamura Y, Yanagawa H, Wakui K, Fukushima Y, Kawasaki T, Nakamura Y, Hata A 2007 A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12. J Hum Genet 52:179-190 (Pubitemid 46185112)
21. Maury CP, Salo E, Pelkonen P 1989 Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease. J Lab Clin Med 113:651-654 (Pubitemid 19128736)
22. Matsubara T, Furukawa S, Yabuta K 1990 Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol 56:29-36 (Pubitemid 20220882)
23. Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS 2004 Infliximab as a novel therapy for refractory Kawasaki disease. J Rheumatol 31:808-810 (Pubitemid 38451274)
24. Burns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD, Balfour I, Shen CA, Michel ED, Shulman ST, Melish ME 2005 Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 146:662-667 (Pubitemid 40616253)
25. Saji T, Kemmotsu Y 2006 Infliximab for Kawasaki syndrome. J Pediatr 149:426
26. Kamizono S, Yamada A, Higuchi T, Kato H, Itoh K 1999 Analysis of tumor necrosis factor-alpha production and polymorphisms of the tumor necrosis factor-alpha gene in individuals with a history of Kawasaki disease. Pediatr Int 41:341-345 (Pubitemid 29376971)
27. Quasney MW, Bronstein DE, Cantor RM, Zhang Q, Stroupe C, Shike H, Bastian JF, Matsubara T, Fujiwara M, Akimoto K, Newburger JW, Burns JC 2001 Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease. Pediatr Res 49:686-690 (Pubitemid 32390859)
28. Chien YH, Chang KW, Yang YH, Lu MY, Lin YT, Chiang BL 2003 Association between levels of TNF-alpha and TNF-alpha promoter -308 A/A polymorphism in children with Kawasaki disease. J Formos Med Assoc 102:147-150
29. Ahn SY, Jang GC, Shin JS, Shin KM, Kim DS 2003 Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea. Yonsei Med J 44:1021-1026 (Pubitemid 38081569)
30. Cheung YF, Huang GY, Chen SB, Liu XQ, Xi L, Liang XC, Huang MR, Chen S, Huang LS, Liu XQ, Chan KW, Lau YL 2008 Inflammatory gene polymorphisms and susceptibility to Kawasaki disease and its arterial sequelae. Pediatrics 122:e608-e614
31. Burns JC, Shimizu C, Shike H, Newburger JW, Sundel RP, Baker AL, Matsubara T, Ishikawa Y, Brophy VA, Cheng S, Grow MA, Steiner LL, Kono N, Cantor RM 2005 Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes Immun 6:438-444 (Pubitemid 43090520)
32. Wu SF, Chang JS, Wan L, Tsai CH, Tsai FJ 2005 Association of IL-1Ra gene polymorphism, but no association of IL-1beta and IL-4 gene polymorphisms, with Kawasaki disease. J Clin Lab Anal 19:99-102 (Pubitemid 40746133)
33. Huang FY, Chang TY, Chen MR, Lee HC, Chiu NC, Chi H, Hsu CH, Lin SP, Liu HF, Chen WF, Chu CC, Lin M, Lee YJ 2008 The -590 C/T and 8375 A/G interleukin-4 polymorphisms are not associated with Kawasaki disease in Taiwanese children. Hum Immunol 69:52-57
34. Jibiki T, Terai M, Shima M, Ogawa A, Hamada H, Kanazawa M, Yamamoto S, Oana S, Kohno Y 2001 Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease. Arthritis Rheum 44:2211-2212
35. Burns JC, Shimizu C, Gonzalez E, Kulkarni H, Patel S, Shike H, Sundel RS, Newburger JW, Ahuja SK 2005 Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J Infect Dis 192:344-349 (Pubitemid 40993406)
36. Sohn MH, Hur MW, Kim DS 2001 Interleukin 6 gene promoter polymorphism is not associated with Kawasaki disease. Genes Immun 2:357-362 (Pubitemid 33674249)
37. Jin HS, Kim HB, Kim BS, Lee JK, Seo EJ, Yoo HW, Park IS, Hong YM, Hong SJ 2007 The IL-10 (-627 A/C) promoter polymorphism may be associated with coronary aneurysms and low serum albumin in Korean children with Kawasaki disease. Pediatr Res 61:584-587
38. Hsueh KC, Lin YJ, Chang JS, Wan L, Tsai YH, Tsai CH, Chen CP, Tsai FJ 2008 Influence of interleukin 18 promoter polymorphisms in susceptibility to Kawasaki disease in Taiwan. J Rheumatol 35:1408-1413 (Pubitemid 352000793)
39. Jhang WK, Kang MJ, Jin HS, Yu J, Kim BJ, Kim BS, Lee JK, Seo EJ, Yoo HW, Park IS, Hong YM, Hong SJ 2009 The CCR5 (-2135C/T) polymorphism may be associated with the development of Kawasaki disease in Korean Children. J Clin Immunol 29:22-28
40. Breunis WB, Biezeveld MH, Geissler J, Kuipers IM, Lam J, Ottenkamp J, Hutchinson A, Welch R, Chanock SJ, Kuijpers TW 2007 Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease. Clin Exp Immunol 150:83-90 (Pubitemid 47383291)
41. Ferrara N 2003 The biology of VEGF and its receptors. Nat Med 9:669-676
42. Ohno T, Igarashi H, Inoue K, Akazawa K, Joho K, Hara T 2000 Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr 159:424-429 (Pubitemid 30329107)
43. Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N, Mizuno Y, Hara T 2004 Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 56:953-959 (Pubitemid 39552779)
44. Breunis WB, Biezeveld MH, Geissler J, Ottenkamp J, Kuipers IM, Lam J, Hutchinson A, Welch R, Chanock SJ, Kuijpers TW 2006 Vascular endothelial growth factor gene haplotypes in Kawasaki disease. Arthritis Rheum 54:1588-1594
45. Hsueh KC, Lin YJ, Chang JS, Wan L, Tsai YH, Tsai CH, Chen CP, Tsai FJ 2008 Association of vascular endothelial growth factor C-634 g polymorphism in Taiwanese children with Kawasaki disease. Pediatr Cardiol 29:292-296
46. Huang FY, Chang TY, Chen MR, Lee HC, Chi H, Chiu NC, Hsu CH, Lin SP, Kao HA, Chen WF, Chan HW, Liu HF, Chu CC, Lin M, Lee YJ 2008 Lack of association of the vascular endothelial growth factor gene polymorphisms with Kawasaki disease in Taiwanese children. J Clin Immunol 28:322-328
47. Takeuchi K, Yamamoto K, Kataoka S, Kakihara T, Tanaka A, Sato S, Uchiyama M 1997 High incidence of angiotensin I converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm. Eur J Pediatr 156:266-268 (Pubitemid 27142144)
48. Wu SF, Chang JS, Peng CT, Shi YR, Tsai FJ 2004 Polymorphism of angiotensin-1 converting enzyme gene and Kawasaki disease. Pediatr Cardiol 25:529-533 (Pubitemid 39382823)
49. Shim YH, Kim HS, Sohn S, Hong YM 2006 Insertion/deletion polymorphism of angiotensin converting enzyme gene in Kawasaki disease. J Korean Med Sci 21:208-211
50. Fukazawa R, Sonobe T, Hamamoto K, Hamaoka K, Sakata K, Asano T, Imai T, Kamisago M, Ohkubo T, Uchikoba Y, Ikegami E, Watanabe M, Ogawa S 2004 Possible synergic effect of angiotensin-I converting enzyme gene insertion/deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease. Pediatr Res 56:597-601 (Pubitemid 39280914)
51. Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Nakano H, Nagasaka H, Sasaki N, Asano H, Kyo S, Yokote Y 2001 Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation 104:860-863 (Pubitemid 32778033)
52. Furuno K, Takada H, Yamamoto K, Ikeda K, Ohno T, Khajoee V, Mizuno Y, Hara T 2007 Tissue inhibitor of metalloproteinase 2 and coronary artery lesions in Kawasaki disease. J Pediatr 151:155-160 (Pubitemid 47069404)
53. Park JA, Shin KS, Kim YW 2005 Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease. J Korean Med Sci 20:607-611 (Pubitemid 41265139)
54. Ikeda K, Ihara K, Yamaguchi K, Muneuchi J, Ohno T, Mizuno Y, Hara T 2008 Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease. Pediatr Res 63:182-185
55. Hong YM, Jin HS, Park IS, Hong SJ 2008 Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children. Heart Vessels 23:341-347
56. Nishimura S, Zaitsu M, Hara M, Yokota G, Watanabe M, Ueda Y, Imayoshi M, Ishii E, Tasaki H, Hamasaki Y 2003 A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. J Pediatr 143:357-362 (Pubitemid 37188321)
57. Biezeveld MH, Kuipers IM, Geissler J, Lam J, Ottenkamp JJ, Hack CE, Kuijpers TW 2003 Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease. Lancet 361:1268-1270 (Pubitemid 36428583)
58. Biezeveld MH, Geissler J, Weverling GJ, Kuipers IM, Lam J, Ottenkamp J, Kuijpers TW 2006 Polymorphisms in the mannose-binding lectin gene as determinants of age-defined risk of coronary artery lesions in Kawasaki disease. Arthritis Rheum 54:369-376 (Pubitemid 43122222)
59. Cheung YF, Ho MH, Ip WK, Fok SF, Yung TC, Lau YL 2004 Modulating effects of mannose binding lectin genotype on arterial stiffness in children after Kawasaki disease. Pediatr Res 56:591-596
60. Ouchi K, Suzuki Y, Shirakawa T, Kishi F 2003 Polymorphism of SLC11A1 (formerly NRAMP1) gene confers susceptibility to Kawasaki disease. J Infect Dis 187:326-329 (Pubitemid 36132649)
61. Tsukahara H, Hiraoka M, Saito M, Nishida K, Kobata R, Tsuchida S, Toyooka M, Kimura H, Gejyo F, Mayumi M 2000 Methylenetetrahydrofolate reductase polymorphism in Kawasaki disease. Pediatr Int 42:236-240 (Pubitemid 30409335)
62. Taniuchi S, Masuda M, Teraguchi M, Ikemoto Y, Komiyama Y, Takahashi H, Kino M, Kobayashi Y 2005 Polymorphism of Fc gamma RIIa may affect the efficacy of gamma-globulin therapy in Kawasaki disease. J Clin Immunol 25:309-313 (Pubitemid 41204254)
63. Biezeveld M, Geissler J, Merkus M, Kuipers IM, Ottenkamp J, Kuijpers T 2007 The involvement of Fc gamma receptor gene polymorphisms in Kawasaki disease. Clin Exp Immunol 147:106-111 (Pubitemid 44915561)
64. Kanai M, Tanabe S, Okada M, Suzuki H, Niki T, Katsuura M, Akiba T, Hayasaka K 2003 Polymorphisms of heme oxygenase-1 and bilirubin UDP-glucuronosyltransferase genes are not associated with Kawasaki disease susceptibility. Tohoku J Exp Med 200:155-159 (Pubitemid 37258814)
65. Huang Y, Lee YJ, Chen MR, Hsu CH, Lin SP, Sung TC, Chang SC, Chang JG 2000 Polymorphism of transmembrane region of MICA gene and Kawasaki disease. Exp Clin Immunogenet 17:130-137 (Pubitemid 30481302)
66. Minami T, Suzuki H, Takeuchi T, Uemura S, Sugatani J, Yoshikawa N 2005 A polymorphism in plasma platelet-activating factor acetylhydrolase is involved in resistance to immunoglobulin treatment in Kawasaki disease. J Pediatr 147:78-83 (Pubitemid 40981150)
67. Khajoee V, Kariyazono H, Ohno T, Ihara K, Mizuno Y, Kusuhara K, Hara T 2003 Inducible and endothelial constitutive nitric oxide synthase gene polymorphisms in Kawasaki disease. Pediatr Int 45:130-134 (Pubitemid 36578928)
68. Onouchi Y, Onoue S, Tamari M, Wakui K, Fukushima Y, Yashiro M, Nakamura Y, Yanagawa H, Kishi F, Ouchi K, Terai M, Hamamoto K, Kudo F, Aotsuka H, Sato Y, Nariai A, Kaburagi Y, Miura M, Saji T, Kawasaki T, Nakamura Y, Hata A 2004 CD40 ligand gene and Kawasaki disease. Eur J Hum Genet 12:1062-1068 (Pubitemid 39600134)
69. Huang FY, Chang TY, Chen MR, Chiu NC, Chi H, Lee HC, Lin SP, Chen CK, Chan HW, Chen WF, Liu HF, Chu CC, Lin M, Lee YJ 2008 Genetic polymorphisms in the CD40 ligand gene and Kawasaki disease. J Clin Immunol 28:405-410
70. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, Nakamura Y, Yanagawa H, Wakui K, Fukushima Y, Kishi F, Hamamoto K, Terai M, Sato Y, Ouchi K, Saji T, Nariai A, Kaburagi Y, Yoshikawa T, Suzuki K, Tanaka T, Nagai T, Cho H, Fujino A, Sekine A, Nakamichi R, Tsunoda T, Kawasaki T, Nakamura Y, Hata A 2008 ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 40:35-42
71. Berridge MJ, Irvine RF 1989 Inositol phosphates and cell signalling. Nature 341:197-205
72. Rao A, Luo C, Hogan PG 1997 Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15:707-747 (Pubitemid 27169297)
73. Crabtree GR, Olson EN 2002 NFAT signaling: choreographing the social lives of cells. Cell 109:S67-S79
74. Macian F 2005 NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 5:472-484 (Pubitemid 40835035)
75. Liu R, McEachin RC, States DJ 2003 Computationally identifying novel NF-kappa B-regulated immune genes in the human genome. Genome Res 13:654-661 (Pubitemid 36511924)
76. Pouillon V, Hascakova-Bartova R, Pajak B, Adam E, Bex F, Dewaste V, Van Lint C, Leo O, Erneux C, Schurmans S 2003 Inositol 1,3,4,5-tetrakisphosphate is essential for T lymphocyte development. Nat Immunol 4:1136-1143
77. Miller AT, Sandberg M, Huang YH, Young M, Sutton S, Sauer K, Cooke MP 2007 Production of Ins(1,3,4,5)P4 mediated by the kinase Itpkb inhibits store-operated calcium channels and regulates B cell selection and activation. Nat Immunol 8:514-521
78. Huang YH, Grasis JA, Miller AT, Xu R, Soonthornvacharin S, Andreotti AH, Tsoukas CD, Cooke MP, Sauer K 2007 Positive regulation of Itk PH domain function by soluble IP4. Science 316:886-889 (Pubitemid 46764278)